An international study finds that AI surpasses average radiologists in detecting pancreatic cancer on CT scans using a newly developed benchmark and dataset.
Key Details
- 1The study was led by Radboudumc and published in The Lancet Oncology.
- 2A confidential dataset of nearly 400 patient CT scans was assessed by international experts and used to benchmark over 250 submitted AI models.
- 3The best AI model made correct assessments in 92% of scans, compared to 88% for radiologists, and produced 38% fewer false positives.
- 4The AI outperformed the average radiologist but requires further validation before clinical adoption.
- 5The research was funded by the Hanarth Fund and the EU’s Horizon Europe program.
Why It Matters
This study provides strong evidence for the potential of AI to support radiologists in diagnosing pancreatic cancer, a particularly deadly and hard-to-detect disease. The validated benchmark and international collaboration pave the way for further clinical development and adoption of AI in abdominal CT interpretation.
Source
EurekAlert
Related News
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.
•EurekAlert
AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.
•EurekAlert
Molecular Test BiliSeq Greatly Improves Bile Duct Cancer Detection
The BiliSeq molecular test developed at UPMC doubled detection sensitivity for bile duct cancer compared to standard pathology.